Impact of Crystalloid or Albumin Priming of the Heart–Lung Machine on Inhospital Outcome after Coronary Artery Bypass Surgery
20 November 2017
19 June 2018
26 July 2018 (online)
Background Crystalloid priming is a cost-effective, free from immunological reactions, and independent from human plasma delivery. However, there is some debate on the negative impact of low plasma colloid pressure and higher incidence of systemic inflammatory response syndrome (SIRS). The aim of the study was to rule out any adverse effects of crystalloid priming on the postoperative outcome.
Methods We investigated 520 consecutive patients, including emergencies, who had isolated on-pump coronary artery bypass grafting in 2009 by retrospective analysis in our clinic. Crystalloid priming (n = 294) was introduced as an alternative to albumin (n = 226). Reviewing patient charts and IT-based data generated a dataset of perioperative parameters.
Results There were no differences with respect to demographical data and preexisting comorbidities between both groups. Despite equal perfusion times, more volume had to be substituted during extracorporeal circulation following crystalloid priming. However, this did not influence the inhospital outcomes. According to the definition of the “Sepsis-3 Guidelines,” the incidence of SIRS was similar. There was no difference in the need for a vasopressor treatment, and only transient higher serum lactate levels were found in the crystalloid group. The incidence of neurologic and organ-related adverse events, as well as 30-day mortality was comparable.
Conclusion The use of crystalloid priming is safe in coronary artery bypass grafting surgery in adults. However, there might be a greater need for crystalloid fluids during surgery.
- 1 Gibbon Jr JH. The development of the heart-lung apparatus. Rev Surg 1970; 27 (04) 231-244
- 2 Mack MJ. Advances in the treatment of coronary artery disease. Ann Thorac Surg 2003; 76 (06) S2240-S2245
- 3 Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69 (04) 1198-1204
- 4 Davies SW, Duffy JP, Wickens DG. , et al. Time-course of free radical activity during coronary artery operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993; 105 (06) 979-987
- 5 Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001; 94 (06) 1133-1138
- 6 Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 1996; 98 (05) 1081-1087
- 7 Clarkson B, Thompson D, Horwith M, Luckey EH. Cyclical edema and shock due to increased capillary permeability. Am J Med 1960; 29: 193-216
- 8 Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome. Ann Intern Med 2010; 153 (02) 90-98
- 9 Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003; 75 (02) S715-S720
- 10 Alexiou C, Tang AA, Sheppard SV. , et al. The effect of leucodepletion on leucocyte activation, pulmonary inflammation and respiratory index in surgery for coronary revascularisation: a prospective randomised study. Eur J Cardiothorac Surg 2004; 26 (02) 294-300
- 11 Testa L, Van Gaal WJ, Bhindi R. , et al. Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg 2008; 136 (04) 884-893
- 12 Whitlock RP, Devereaux PJ, Teoh KH. , et al; SIRS Investigators. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet 2015; 386 (10000): 1243-1253
- 13 Kamler M, Pizanis N, Hagl S, Gebhard MM, Jakob H. Extracorporal-circulation-induced leukocyte/endothelial cell interaction is inhibited by dextran. Clin Hemorheol Microcirc 2004; 31 (02) 139-148
- 14 Barner HB. Blood cardioplegia: a review and comparison with crystalloid cardioplegia. Ann Thorac Surg 1991; 52 (06) 1354-1367
- 15 Yu K, Liu Y, Hei F, Li J, Long C. Effect of different albumin concentrations in extracorporeal circuit prime on perioperative fluid status in young children. ASAIO J 2008; 54 (05) 463-466
- 16 Mak MA, Smołka A, Kowalski J. , et al. Can cardiopulmonary bypass system with blood priming become a new standard in coronary surgery?. Kardiol Pol 2016; 74 (08) 726-732
- 17 Shankar-Hari M, Phillips GS, Levy ML. , et al; Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315 (08) 775-787
- 18 Selberg O, Hecker H, Martin M, Klos A, Bautsch W, Köhl J. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 2000; 28 (08) 2793-2798
- 19 Foster PR. Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy. Transfus Med 1999; 9 (01) 3-14
- 20 Haase N, Perner A, Hennings LI. , et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346: f839
- 21 Zarychanski R, Abou-Setta AM, Turgeon AF. , et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309 (07) 678-688
- 22 Hu X, Wu M, Fang Q. A multicenter confirmatory study about precision and practicability of Sepsis-3. [in Chinese ]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2017; 29 (02) 99-105
- 23 Sun P, Ji B, Sun Y. , et al. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion 2013; 28 (03) 238-243
- 24 Trapp C, Schiller W, Mellert F. , et al. Retrograde autologous priming as a safe and easy method to reduce hemodilution and transfusion requirements during cardiac surgery. Thorac Cardiovasc Surg 2015; 63 (07) 628-634
- 25 Vandewiele K, Bové T, De Somer FM. , et al. The effect of retrograde autologous priming volume on haemodilution and transfusion requirements during cardiac surgery. Interact Cardiovasc Thorac Surg 2013; 16 (06) 778-783
- 26 Sirs JA, Glenville B, Stanbridge RL. , et al. The influence of vascular pressure and different primes on the fluid balance of, and oxygen supply to, the patient during CABG. Perfusion 1995; 10 (01) 33-44
- 27 Shinde SB, Golam KK, Kumar P, Patil ND. Blood lactate levels during cardiopulmonary bypass for valvular heart surgery. Ann Card Anaesth 2005; 8 (01) 39-44
- 28 Cheng M, Li JQ, Wu TC, Tian WC. Short-term effects and safety analysis of retrograde autologous blood priming for cardiopulmonary bypass in patients with cardiac valve replacement surgery. Cell Biochem Biophys 2015; 73 (02) 441-446
- 29 Murphy GS, Szokol JW, Nitsun M. , et al. The failure of retrograde autologous priming of the cardiopulmonary bypass circuit to reduce blood use after cardiac surgical procedures. Anesth Analg 2004; 98 (05) 1201-1207 table of contents.
- 30 Saczkowski R, Bernier PL, Tchervenkov CI, Arellano R. Retrograde autologous priming and allogeneic blood transfusions: a meta-analysis. Interact Cardiovasc Thorac Surg 2009; 8 (03) 373-376
- 31 Hwang J, Huh J, Kim J. , et al. The effect of retrograde autologous priming of the cardiopulmonary bypass circuit on cerebral oxygenation. J Cardiothorac Vasc Anesth 2011; 25 (06) 995-999